BioSpace News Archive

Deals

Tilray® Strengthens Presence in Latin America with Acquisition of Alef Biotechnology

Tilray, Inc. today announced that it has completed an acquisition of its existing import and distribution partner Alef Biotechnology SpA (“Alef”).

October 9, 2018
·
4 min read
Policy

AgriPhage™-Fire Blight and AgriPhage™-Citrus Canker Approved for Use to Control Bacterial Disease in Citrus and Pome Fruit

OmniLytics, Inc. announces today that the EPA has approved two new bacteriophage products, AgriPhage™-Fire Blight and AgriPhage™-Citrus Canker, for the control of their namesake diseases.

October 9, 2018
·
3 min read
Pharm Country

Topix Pharmaceuticals, Inc. Launches Backbar Line

Physicians Can Now Use Their Own Branding On A Targeted Treatment Regimen

October 9, 2018
·
2 min read
Policy

Check-Cap Announces IDE Submission to FDA for Its C-Scan® System

If Approved, U.S. Pilot Study Anticipated to Commence in 4Q 2018

October 9, 2018
·
3 min read
Biotech Bay

Genentech to Present New Positive Data from Its Broad Cancer Immunotherapy Program and across a Wide Range of Cancers at the European Society for Medical Oncology (ESMO) 2018 Congress

First positive Phase III study results for a cancer immunotherapy combination in breast cancer, with Tecentriq® plus nab-paclitaxel

October 9, 2018
·
27 min read
BioCapital

SPI Pharma launches Mannogem® XL mannitol, enabling production of difficult-to-compress and problematic formulations

SPI Pharma introduces Mannogem® XL mannitol to the international pharmaceutical market. It is an innovative approach to mannitol, designed to improve the formulation experience and enhance formulation performance.

October 9, 2018
·
2 min read
Business

NuVasive Announces Strategic Partnership With Biedermann Technologies To Access Intellectual Property And Co-Develop State-of-the-Art Complex Spine Solutions

Biedermann Technologies’ leading innovations to be available with NuVasive’s RELINE® posterior fixation system to create differentiated adult and pediatric technology solutions

October 9, 2018
·
5 min read
Strekin AG Announces the Publication of Key in vivo Data on Mechanisms of STR001 in the Treatment of Sensorineural Hearing Loss

Strekin AG today announced the publication of key scientific data on efficacy and mechanism of action of its lead drug candidate, STR001, in preclinical models of sensorineural hearing loss.

October 9, 2018
·
2 min read
Business

FSD Pharma Begins Construction of Heritage Museum and Flagship Dispensary in Ontario

FSD Pharma Inc. is pleased to announce that construction has commenced of its heritage museum and flagship dispensary at the former Kraft plant in Cobourg, Ontario, headquarters of its wholly-owned subsidiary FV Pharma Inc.

October 9, 2018
·
3 min read
Deals

Axonics® Announces Filing of Registration Statement for Proposed Initial Public Offering

Axonics Modulation Technologies, Inc. announced today that it has filed an S-1 registration statement with the U.S. Securities and Exchange Commission (“SEC”) relating to a proposed public offering of its common stock.

October 9, 2018
·
2 min read